Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease

NCT06336798 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT06336798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06336798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pioglitazone on Mitochondrial Metabolism in Pulmonary Hypertension Due to Chronic Lung Disease
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Recruiting
Start date
December 17, 2024
Completion date
February 29, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, pulmonary hypertension due to lung diseases